LPTX icon

Leap Therapeutics

72 hedge funds and large institutions have $32.7M invested in Leap Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.51% less ownership

Funds ownership: 4.26%3.75% (-0.51%)

24% less capital invested

Capital invested by funds: $43.2M → $32.7M (-$10.6M)

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$255K
Puts
$27K
Net Calls
Net Calls Change

Top Sellers

1 -$619K
2 -$575K
3 -$422K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$300K
5
Renaissance Technologies
Renaissance Technologies
New York
-$202K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.58M
2
$3.52M
3
$3.22M
4
$2.87M
5
$2.35M
6
$1.99M
7
$1.17M
8
$1.1M
9
$1.04M
10
$986K
11
$939K
12
$792K
13
$704K
14
$626K
15
$547K
16
$535K
17
$493K
18
$416K
19
$364K
20
$344K
21
$263K
22
$233K
23
$156K
24
$133K
25
$115K